|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1701 to 1800 out of 2663 for Psen1

Category restricted to Publication (x)

0.039s

Categories

Category: Publication
Type Details Score
Publication
First Author: Wang MD
Year: 2023
Journal: Acta Pharmacol Sin
Title: Salvianolic acid B ameliorates retinal deficits in an early-stage Alzheimer's disease mouse model through downregulating BACE1 and Aβ generation.
Volume: 44
Issue: 11
Pages: 2151-2168
Publication  
First Author: Na H
Year: 2020
Journal: Neuropharmacology
Title: Characterization of the effects of calcitonin gene-related peptide receptor antagonist for Alzheimer's disease.
Volume: 168
Pages: 108017
Publication  
First Author: Lin SY
Year: 2019
Journal: Neuroscience
Title: Ozone Inhibits APP/Aβ Production and Improves Cognition in an APP/PS1 Transgenic Mouse Model.
Volume: 418
Pages: 110-121
Publication  
First Author: Tajmim A
Year: 2021
Journal: Nutrients
Title: (-)-Oleocanthal Nutraceuticals for Alzheimer's Disease Amyloid Pathology: Novel Oral Formulations, Therapeutic, and Molecular Insights in 5xFAD Transgenic Mice Model.
Volume: 13
Issue: 5
Publication
First Author: Chen PC
Year: 2022
Journal: Nat Aging
Title: Alzheimer's disease-associated U1 snRNP splicing dysfunction causes neuronal hyperexcitability and cognitive impairment.
Volume: 2
Issue: 10
Pages: 923-940
Publication  
First Author: Fernández-Mendívil C
Year: 2020
Journal: Antioxidants (Basel)
Title: Aging and Progression of Beta-Amyloid Pathology in Alzheimer's Disease Correlates with Microglial Heme-Oxygenase-1 Overexpression.
Volume: 9
Issue: 7
Publication  
First Author: Kim J
Year: 2021
Journal: Int J Mol Sci
Title: Donepezil Regulates LPS and Aβ-Stimulated Neuroinflammation through MAPK/NLRP3 Inflammasome/STAT3 Signaling.
Volume: 22
Issue: 19
Publication
First Author: Chang SK
Year: 2021
Journal: NMR Biomed
Title: Mapping of microvascular architecture in the brain of an Alzheimer's disease mouse model using MRI.
Volume: 34
Issue: 6
Pages: e4481
Publication
First Author: Sosna J
Year: 2018
Journal: Mol Neurodegener
Title: Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease.
Volume: 13
Issue: 1
Pages: 11
Publication
First Author: Miao H
Year: 2018
Journal: Mol Neurobiol
Title: Anesthetic Isoflurane or Desflurane Plus Surgery Differently Affects Cognitive Function in Alzheimer's Disease Transgenic Mice.
Volume: 55
Issue: 7
Pages: 5623-5638
Publication
First Author: Bachiller S
Year: 2022
Journal: J Neuroinflammation
Title: Early-life stress elicits peripheral and brain immune activation differently in wild type and 5xFAD mice in a sex-specific manner.
Volume: 19
Issue: 1
Pages: 151
Publication  
First Author: Ohno K
Year: 2021
Journal: Contrast Media Mol Imaging
Title: GlyCEST: Magnetic Resonance Imaging of Glycine-Distribution in the Normal Murine Brain and Alterations in 5xFAD Mice.
Volume: 2021
Pages: 8988762
Publication  
First Author: Reid GA
Year: 2015
Journal: Neuroscience
Title: Butyrylcholinesterase-knockout reduces brain deposition of fibrillar β-amyloid in an Alzheimer mouse model.
Volume: 298
Pages: 424-35
Publication  
First Author: Khavinson V
Year: 2021
Journal: Pharmaceuticals (Basel)
Title: Neuroprotective Effects of Tripeptides-Epigenetic Regulators in Mouse Model of Alzheimer's Disease.
Volume: 14
Issue: 6
Publication
First Author: Muraleedharan A
Year: 2021
Journal: Glia
Title: Protein kinase C eta is activated in reactive astrocytes of an Alzheimer's disease mouse model: Evidence for its immunoregulatory function in primary astrocytes.
Volume: 69
Issue: 3
Pages: 697-714
Publication
First Author: Igarashi H
Year: 2014
Journal: Neurol Res
Title: Water influx into cerebrospinal fluid is significantly reduced in senile plaque bearing transgenic mice, supporting beta-amyloid clearance hypothesis of Alzheimer's disease.
Volume: 36
Issue: 12
Pages: 1094-8
Publication
First Author: Zernov N
Year: 2024
Journal: Sci Rep
Title: Discovery of a novel piperazine derivative, cmp2: a selective TRPC6 activator suitable for treatment of synaptic deficiency in Alzheimer's disease hippocampal neurons.
Volume: 14
Issue: 1
Pages: 23512
Publication
First Author: Banerjee TD
Year: 2021
Journal: Mol Neurobiol
Title: Mitochondrial PKA Is Neuroprotective in a Cell Culture Model of Alzheimer's Disease.
Volume: 58
Issue: 7
Pages: 3071-3083
Publication  
First Author: Lee SH
Year: 2023
Journal: Int J Mol Sci
Title: Second Wave, Late-Stage Neuroinflammation in Cleared Brains of Aged 5xFAD Alzheimer's Mice Detected by Macrolaser Light Sheet Microscopy Imaging.
Volume: 24
Issue: 23
Publication
First Author: Gupta DP
Year: 2023
Journal: Mol Brain
Title: Knee osteoarthritis accelerates amyloid beta deposition and neurodegeneration in a mouse model of Alzheimer's disease.
Volume: 16
Issue: 1
Pages: 1
Publication  
First Author: Makarava N
Year: 2023
Journal: Cells
Title: Region-Specific Homeostatic Identity of Astrocytes Is Essential for Defining Their Response to Pathological Insults.
Volume: 12
Issue: 17
Publication  
First Author: Zagorski K
Year: 2023
Journal: Int J Mol Sci
Title: Novel Vaccine against Pathological Pyroglutamate-Modified Amyloid Beta for Prevention of Alzheimer's Disease.
Volume: 24
Issue: 12
Publication
First Author: Maezawa I
Year: 2018
Journal: Brain
Title: Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.
Volume: 141
Issue: 2
Pages: 596-612
Publication
First Author: Lucero EM
Year: 2022
Journal: iScience
Title: Increased KIF11/kinesin-5 expression offsets Alzheimer Aβ-mediated toxicity and cognitive dysfunction.
Volume: 25
Issue: 11
Pages: 105288
Publication
First Author: Guo C
Year: 2024
Journal: Sci Rep
Title: Plasminogen degrades α-synuclein, Tau and TDP-43 and decreases dopaminergic neurodegeneration in mouse models of Parkinson's disease.
Volume: 14
Issue: 1
Pages: 8581
Publication
First Author: Rejc L
Year: 2022
Journal: Alzheimers Res Ther
Title: Longitudinal evaluation of neuroinflammation and oxidative stress in a mouse model of Alzheimer disease using positron emission tomography.
Volume: 14
Issue: 1
Pages: 80
Publication  
First Author: Yoshida N
Year: 2022
Journal: Biomedicines
Title: Relationship between Cognitive Dysfunction and Age-Related Variability in Oxidative Markers in Isolated Mitochondria of Alzheimer's Disease Transgenic Mouse Brains.
Volume: 10
Issue: 2
Publication
First Author: Jin LW
Year: 2023
Journal: Glia
Title: The role of FUT8-catalyzed core fucosylation in Alzheimer's amyloid-β oligomer-induced activation of human microglia.
Volume: 71
Issue: 5
Pages: 1346-1359
Publication
First Author: Dunham SJB
Year: 2022
Journal: mBio
Title: Longitudinal Analysis of the Microbiome and Metabolome in the 5xfAD Mouse Model of Alzheimer's Disease.
Volume: 13
Issue: 6
Pages: e0179422
Publication
First Author: Oblak AL
Year: 2022
Journal: Alzheimers Dement (N Y)
Title: Prophylactic evaluation of verubecestat on disease- and symptom-modifying effects in 5XFAD mice.
Volume: 8
Issue: 1
Pages: e12317
Publication  
First Author: Lin S
Year: 2018
Journal: Neurosci Lett
Title: Upregulated BMP6 pathway involved in the pathogenesis of Aβ toxicity in vivo.
Volume: 664
Pages: 152-159
Publication
First Author: Boza-Serrano A
Year: 2018
Journal: Sci Rep
Title: Innate immune alterations are elicited in microglial cells before plaque deposition in the Alzheimer's disease mouse model 5xFAD.
Volume: 8
Issue: 1
Pages: 1550
Publication
First Author: Onos KD
Year: 2022
Journal: Alzheimers Dement (N Y)
Title: Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL-AD preclinical testing core study.
Volume: 8
Issue: 1
Pages: e12329
Publication
First Author: Chen C
Year: 2022
Journal: Transl Psychiatry
Title: Early impairment of cortical circuit plasticity and connectivity in the 5XFAD Alzheimer's disease mouse model.
Volume: 12
Issue: 1
Pages: 371
Publication  
First Author: Park H
Year: 2020
Journal: Cells
Title: The MAO Inhibitor Tranylcypromine Alters LPS- and Aβ-Mediated Neuroinflammatory Responses in Wild-type Mice and a Mouse Model of AD.
Volume: 9
Issue: 9
Publication
First Author: Vrancx C
Year: 2021
Journal: Mol Neurobiol
Title: Mechanism of Cellular Formation and In Vivo Seeding Effects of Hexameric β-Amyloid Assemblies.
Volume: 58
Issue: 12
Pages: 6647-6669
Publication  
First Author: Lim HS
Year: 2023
Journal: Free Radic Biol Med
Title: Changes in RBM47 expression based on the timing of melatonin administration and its effects on Nrf2 activity in the hippocampus.
Volume: 208
Pages: 794-806
Publication  
First Author: Kim YJ
Year: 2024
Journal: Brain Sci
Title: Oral Administration of Probiotic Bacteria Alleviates Tau Phosphorylation, Aβ Accumulation, Microglia Activation, and Memory Loss in 5xFAD Mice.
Volume: 14
Issue: 3
Publication
First Author: Leng L
Year: 2022
Journal: Nat Metab
Title: Microglial hexokinase 2 deficiency increases ATP generation through lipid metabolism leading to β-amyloid clearance.
Volume: 4
Issue: 10
Pages: 1287-1305
Publication
First Author: Neuner SM
Year: 2019
Journal: Neuron
Title: Harnessing Genetic Complexity to Enhance Translatability of Alzheimer's Disease Mouse Models: A Path toward Precision Medicine.
Volume: 101
Issue: 3
Pages: 399-411.e5
Publication  
First Author: Gendron WH
Year: 2024
Journal: Physiol Behav
Title: Intranasal insulin treatment ameliorates spatial memory, muscular strength, and frailty deficits in 5xFAD mice.
Volume: 281
Pages: 114583
Publication
First Author: López A
Year: 2018
Journal: J Neuroinflammation
Title: Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer's disease.
Volume: 15
Issue: 1
Pages: 158
Publication  
First Author: Noh H
Year: 2014
Journal: Neuroscience
Title: Age-dependent effects of valproic acid in Alzheimer's disease (AD) mice are associated with nerve growth factor (NGF) regulation.
Volume: 266
Pages: 255-65
Publication  
First Author: Park J
Year: 2021
Journal: Sci Adv
Title: O-GlcNAcylation ameliorates the pathological manifestations of Alzheimer's disease by inhibiting necroptosis.
Volume: 7
Issue: 3
Publication  
First Author: Wierczeiko A
Year: 2021
Journal: Cells
Title: Voluntary Wheel Running Did Not Alter Gene Expression in 5xfad Mice, but in Wild-Type Animals Exclusively after One-Day of Physical Activity.
Volume: 10
Issue: 3
Publication  
First Author: Lee HJ
Year: 2020
Journal: Free Radic Biol Med
Title: The novel DYRK1A inhibitor KVN93 regulates cognitive function, amyloid-beta pathology, and neuroinflammation.
Volume: 160
Pages: 575-595
Publication
First Author: Upadhyay A
Year: 2023
Journal: Mol Neurodegener
Title: Amyloid fibril proteomics of AD brains reveals modifiers of aggregation and toxicity.
Volume: 18
Issue: 1
Pages: 61
Publication  
First Author: Lee WS
Year: 2022
Journal: Nutrients
Title: The Potential Neuroprotective Effects of Extracts from Oat Seedlings against Alzheimer's Disease.
Volume: 14
Issue: 19
Publication  
First Author: Pijewski RS
Year: 2022
Journal: Neurosci Lett
Title: Distinct profiles of cellular senescence-associated gene expression in the aged, diseased or injured central nervous system.
Volume: 772
Pages: 136480
Publication
First Author: Fastenau C
Year: 2023
Journal: Geroscience
Title: Increased α-2,6 sialic acid on microglia in amyloid pathology is resistant to oseltamivir.
Volume: 45
Issue: 3
Pages: 1539-1555
Publication
First Author: Liu Q
Year: 2023
Journal: Cell Biosci
Title: Intensity-dependent gamma electrical stimulation regulates microglial activation, reduces beta-amyloid load, and facilitates memory in a mouse model of Alzheimer's disease.
Volume: 13
Issue: 1
Pages: 138
Publication
First Author: Svensson M
Year: 2020
Journal: Sci Rep
Title: Voluntary running does not reduce neuroinflammation or improve non-cognitive behavior in the 5xFAD mouse model of Alzheimer's disease.
Volume: 10
Issue: 1
Pages: 1346
Publication
First Author: Kim KR
Year: 2022
Journal: Cell Death Differ
Title: S-Nitrosylation of cathepsin B affects autophagic flux and accumulation of protein aggregates in neurodegenerative disorders.
Volume: 29
Issue: 11
Pages: 2137-2150
Publication
First Author: Grochowska KM
Year: 2017
Journal: EMBO Rep
Title: Posttranslational modification impact on the mechanism by which amyloid-β induces synaptic dysfunction.
Volume: 18
Issue: 6
Pages: 962-981
Publication
First Author: Rimal S
Year: 2021
Journal: Acta Neuropathol Commun
Title: Inefficient quality control of ribosome stalling during APP synthesis generates CAT-tailed species that precipitate hallmarks of Alzheimer's disease.
Volume: 9
Issue: 1
Pages: 169
Publication  
First Author: Feng B
Year: 2021
Journal: Sci Adv
Title: Planar cell polarity signaling components are a direct target of β-amyloid-associated degeneration of glutamatergic synapses.
Volume: 7
Issue: 34
Publication  
First Author: Ramamoorthy K
Year: 2022
Journal: Neurobiol Dis
Title: Alzheimer's disease is associated with disruption in thiamin transport physiology: A potential role for neuroinflammation.
Volume: 171
Pages: 105799
Publication
First Author: Raha S
Year: 2021
Journal: Sci Signal
Title: Activation of PPARα enhances astroglial uptake and degradation of β-amyloid.
Volume: 14
Issue: 706
Pages: eabg4747
Publication
First Author: Park JC
Year: 2017
Journal: Aging Cell
Title: Annexin A1 restores Aβ1-42 -induced blood-brain barrier disruption through the inhibition of RhoA-ROCK signaling pathway.
Volume: 16
Issue: 1
Pages: 149-161
Publication  
First Author: Jeong YA
Year: 2023
Journal: Toxins (Basel)
Title: Long-Term Administration of Vespa velutina nigrithorax Venom Ameliorates Alzheimer's Phenotypes in 5xFAD Transgenic Mice.
Volume: 15
Issue: 3
Publication  
First Author: Fella E
Year: 2022
Journal: Front Immunol
Title: Pharmacological activation of the C5a receptor leads to stimulation of the β-adrenergic receptor and alleviates cognitive impairment in a murine model of familial Alzheimer's disease.
Volume: 13
Pages: 947071
Publication  
First Author: Choo XY
Year: 2022
Journal: Int J Mol Sci
Title: Novel Anti-Neuroinflammatory Properties of a Thiosemicarbazone-Pyridylhydrazone Copper(II) Complex.
Volume: 23
Issue: 18
Publication  
First Author: Kim J
Year: 2022
Journal: Int J Mol Sci
Title: Effect of cx-DHED on Abnormal Glucose Transporter Expression Induced by AD Pathologies in the 5xFAD Mouse Model.
Volume: 23
Issue: 18
Publication
First Author: Lin W
Year: 2023
Journal: J Neuroinflammation
Title: TNEA therapy promotes the autophagic degradation of NLRP3 inflammasome in a transgenic mouse model of Alzheimer's disease via TFEB/TFE3 activation.
Volume: 20
Issue: 1
Pages: 21
Publication  
First Author: Plachez C
Year: 2023
Journal: Neuroscience
Title: Amyloid Deposition and Dendritic Complexity of Corticocortical Projection Cells in Five Familial Alzheimer's Disease Mouse.
Volume: 512
Pages: 85-98
Publication
First Author: Pierrot N
Year: 2013
Journal: EMBO Mol Med
Title: Amyloid precursor protein controls cholesterol turnover needed for neuronal activity.
Volume: 5
Issue: 4
Pages: 608-25
Publication  
First Author: Gray NE
Year: 2018
Journal: Mol Cell Neurosci
Title: Centella asiatica attenuates hippocampal mitochondrial dysfunction and improves memory and executive function in β-amyloid overexpressing mice.
Volume: 93
Pages: 1-9
Publication
First Author: Wang M
Year: 2019
Journal: Sci Rep
Title: Adiponectin improves long-term potentiation in the 5XFAD mouse brain.
Volume: 9
Issue: 1
Pages: 8918
Publication
First Author: Bocharova OV
Year: 2023
Journal: Brain Pathol
Title: Aβ plaques do not protect against HSV-1 infection in a mouse model of familial Alzheimer's disease, and HSV-1 does not induce Aβ pathology in a model of late onset Alzheimer's disease.
Volume: 33
Issue: 1
Pages: e13116
Publication  
First Author: Spencer NG
Year: 2013
Journal: Neuroimage
Title: Quantitative evaluation of MRI and histological characteristics of the 5xFAD Alzheimer mouse brain.
Volume: 76
Pages: 108-15
Publication  
First Author: Matharu B
Year: 2015
Journal: Neuropeptides
Title: Gadolinium-complexed Aβ-binding contrast agents for MRI diagnosis of Alzheimer's Disease.
Volume: 53
Pages: 63-70
Publication
First Author: Guo Z
Year: 2014
Journal: Cell Stem Cell
Title: In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer's disease model.
Volume: 14
Issue: 2
Pages: 188-202
Publication  
First Author: Parthasarathy R
Year: 2015
Journal: Exp Eye Res
Title: Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin.
Volume: 138
Pages: 134-44
Publication
First Author: Hillmann A
Year: 2012
Journal: Neurobiol Aging
Title: No improvement after chronic ibuprofen treatment in the 5XFAD mouse model of Alzheimer's disease.
Volume: 33
Issue: 4
Pages: 833.e39-50
Publication  
First Author: Rong J
Year: 2023
Journal: Pharmaceuticals (Basel)
Title: Evaluation of [(18)F]Favipiravir in Rodents and Nonhuman Primates (NHP) with Positron Emission Tomography.
Volume: 16
Issue: 4
Publication  
First Author: Han X
Year: 2024
Journal: Front Physiol
Title: Metabolic and vascular imaging markers for investigating Alzheimer's disease complicated by sleep fragmentation in mice.
Volume: 15
Pages: 1456690
Publication    
First Author: Solovyev N
Year: 2021
Journal: J Biol Chem
Title: Cu, Fe and Zn isotope ratios in murine Alzheimer's disease models suggest specific signatures of amyloidogenesis and tauopathy.
Pages: 100292
Publication
First Author: Iannucci J
Year: 2024
Journal: J Neuroinflammation
Title: Traumatic brain injury alters the effects of class II invariant peptide (CLIP) antagonism on chronic meningeal CLIP + B cells, neuropathology, and neurobehavioral impairment in 5xFAD mice.
Volume: 21
Issue: 1
Pages: 165
Publication
First Author: Bigley TM
Year: 2022
Journal: Mol Neurodegener
Title: Murine roseolovirus does not accelerate amyloid-β pathology and human roseoloviruses are not over-represented in Alzheimer disease brains.
Volume: 17
Issue: 1
Pages: 10
Publication  
First Author: Möhle L
Year: 2016
Journal: Acta Neuropathol Commun
Title: Chronic Toxoplasma gondii infection enhances β-amyloid phagocytosis and clearance by recruited monocytes.
Volume: 4
Pages: 25
Publication
First Author: Ying Y
Year: 2022
Journal: Neuromolecular Med
Title: SIRT3 Regulates Neuronal Excitability of Alzheimer's Disease Models in an Oxidative Stress-Dependent Manner.
Volume: 24
Issue: 3
Pages: 261-267
Publication  
First Author: Cho WH
Year: 2014
Journal: Neurosci Lett
Title: ID1201, the ethanolic extract of the fruit of Melia toosendan ameliorates impairments in spatial learning and reduces levels of amyloid beta in 5XFAD mice.
Volume: 583
Pages: 170-5
Publication
First Author: Pereira M
Year: 2023
Journal: Biochim Biophys Acta Mol Basis Dis
Title: Amyloid pathology reduces ELP3 expression and tRNA modifications leading to impaired proteostasis.
Volume: 1870
Issue: 1
Pages: 166857
Publication
First Author: Macdonald IR
Year: 2014
Journal: Curr Alzheimer Res
Title: Early detection of cerebral glucose uptake changes in the 5XFAD mouse.
Volume: 11
Issue: 5
Pages: 450-60
Publication
First Author: Yang EJ
Year: 2017
Journal: J Pharmacol Sci
Title: Alterations in protein phosphorylation in the amygdala of the 5XFamilial Alzheimer's disease animal model.
Volume: 133
Issue: 4
Pages: 261-267
Publication
First Author: Liu J
Year: 2021
Journal: Cell Prolif
Title: Infusion of hESC derived Immunity-and-matrix regulatory cells improves cognitive ability in early-stage AD mice.
Volume: 54
Issue: 8
Pages: e13085
Publication
First Author: Zhang L
Year: 2022
Journal: Proc Natl Acad Sci U S A
Title: Goal discrimination in hippocampal nonplace cells when place information is ambiguous.
Volume: 119
Issue: 11
Pages: e2107337119
Publication
First Author: Herskowitz JH
Year: 2013
Journal: J Neurosci
Title: Pharmacologic inhibition of ROCK2 suppresses amyloid-β production in an Alzheimer's disease mouse model.
Volume: 33
Issue: 49
Pages: 19086-98
Publication
First Author: Wang E
Year: 2017
Journal: J Alzheimers Dis
Title: Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model.
Volume: 56
Issue: 1
Pages: 47-61
Publication  
First Author: Han X
Year: 2022
Journal: EBioMedicine
Title: KIBRA regulates amyloid β metabolism by controlling extracellular vesicles secretion.
Volume: 78
Pages: 103980
Publication
First Author: Rejc L
Year: 2021
Journal: Theranostics
Title: Longitudinal evaluation of a novel BChE PET tracer as an early in vivo biomarker in the brain of a mouse model for Alzheimer disease.
Volume: 11
Issue: 13
Pages: 6542-6559
Publication
First Author: Damisah EC
Year: 2017
Journal: Nat Neurosci
Title: A fluoro-Nissl dye identifies pericytes as distinct vascular mural cells during in vivo brain imaging.
Volume: 20
Issue: 7
Pages: 1023-1032
Publication  
First Author: Karahan H
Year: 2023
Journal: Front Immunol
Title: The effect of Abi3 locus deletion on the progression of Alzheimer's disease-related pathologies.
Volume: 14
Pages: 1102530
Publication
First Author: Jawhar S
Year: 2012
Journal: Neurobiol Aging
Title: Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease.
Volume: 33
Issue: 1
Pages: 196.e29-40
Publication
First Author: Chen R
Year: 2012
Journal: Cell Rep
Title: Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease.
Volume: 2
Issue: 5
Pages: 1329-39
Publication
First Author: Kim K
Year: 2021
Journal: RSC Med Chem
Title: Anti-amyloidogenic indolizino[3,2-c]quinolines as imaging probes differentiating dense-core, diffuse, and coronal plaques of amyloid-β.
Volume: 12
Issue: 11
Pages: 1926-1934
Publication  
First Author: Na H
Year: 2021
Journal: Am J Alzheimers Dis Other Demen
Title: Oral Amylin Treatment Reduces the Pathological Cascade of Alzheimer's Disease in a Mouse Model.
Volume: 36
Pages: 15333175211012867
Publication
First Author: Kalinin S
Year: 2012
Journal: Neurobiol Aging
Title: The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease.
Volume: 33
Issue: 8
Pages: 1651-63
Publication
First Author: Hu J
Year: 2023
Journal: Neuron
Title: Microglial Piezo1 senses Aβ fibril stiffness to restrict Alzheimer's disease.
Volume: 111
Issue: 1
Pages: 15-29.e8
Publication
First Author: Zeng Y
Year: 2015
Journal: J Neurochem
Title: Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease.
Volume: 133
Issue: 1
Pages: 38-52